Vioxx (Rofecoxib) & Celebrex

What are Vioxx (Rofecoxib) & Celebrex?

Learn about these NSAIDs, the recall, & the risks.
www.monheit.com/whatis.asp

What is the problem?

...studies associate Vioxx with heart problems, kidney damage, aseptic menin...
www.monheit.com/damage.asp

Who is responsible for Vioxx (Rofecoxib) injuries?

Safety Risks to patients due to lack of warnings.
www.monheit.com/responsible.asp

What is being done about Rofecoxib?

Class action lawsuit filed against the maker of Vioxx.
www.monheit.com/beingdone.asp

What can you do if Vioxx damaged your kidneys?

You may be entitled to compensation for damages
www.monheit.com/you_do.shtml

Vioxx FAQs

Heart Attacks and Strokes
Free case inquiry form.
www.monheit.com/faqs.asp

Breaking news

Timeline of what Merck knew about Vioxx, and when they knew it

Resources on the web

Medical information

Do I have a  case?

Vioxx (Rofecoxib) received FDA approval May 1999. Celebrex was approved by the US Food and Drug Administration in December 1998.

Research after the fact exposed some of the potential flaws in the original studies that were used to gain FDA approval. The FDA was not completely satisfied with the explanations given by the pharmaceutical companies and, as a result, ordered changes in the labeling information on both Vioxx (Rofecoxib) and Celebrex to reflect the most recent and more accurate information.

Apparently the competition for market share between the makers of Vioxx (Rofecoxib) and the makers of Celebrex may have exacerbated the problems. The manufacturers of the drugs may have believed that they would be competing with older NSAIDs like Ibuprofen. However, similarities between Vioxx and Celebrex forced the pharmaceutical companies to compete with one another. Both of the medications were heavily promoted. In the process, some of the facts about these medications were not included in the warnings.

Merck, the company behind Vioxx (Rofecoxib), appeared to be especially aggressive with its advertising message. In fact, the FDA ordered Merck to tone down their advertised claims about the benefits of Vioxx (Rofecoxib), saying that the ads and promotional material for the drug were "false, lacking in fair balance, or otherwise in violation of the Federal Food, Drug, and Cosmetic Act and applicable regulations".

It now appears that the health and safety of patients was put at risk by the lack of warnings supplied by Merck (the makers of Vioxx) and Pharmacia (the company behind Celebrex). One can only wonder whether the warnings were sufficient, or simply minimal, in order to make profits.

We are not currently accepting new Vioxx cases. You should consult another attorney for an opinion on your case.